Skip to main content

Advertisement

Advertisement

ADVERTISEMENT

July 2011 - FRMC

Feature
07/19/2011

Tori Socha

Tori Socha
The Journal of the American Medical Association presented a summary of a Morbidity and Mortality Weekly Report from the CDC.
The Journal of the American Medical Association presented a summary of a Morbidity and Mortality Weekly Report from the CDC.
The Journal of the American...
07/19/2011
First Report Managed Care
Feature
07/19/2011

Kevin L. Carter

Kevin L. Carter
In the Canadian province of British Columbia, the 2007 incidence of Mycobacterium tuberculosis exceeded the Canadian national average.
In the Canadian province of British Columbia, the 2007 incidence of Mycobacterium tuberculosis exceeded the Canadian national average.
In the Canadian province of...
07/19/2011
First Report Managed Care
Feature
07/19/2011

Christin Melton

Christin Melton
Treatment-related metabolic effects are a concern for adults who depend on long-term drug therapy to prevent seizures.
Treatment-related metabolic effects are a concern for adults who depend on long-term drug therapy to prevent seizures.
Treatment-related metabolic...
07/19/2011
First Report Managed Care
Feature
07/19/2011

Christin Melton

Christin Melton
Honolulu—A 2-year trial of patients with Parkinson’s disease (PD) and motor fluctuations found the addition of daily safinamide increased the amount of time each day in which patients experienced symptom relief with levodopa (ON time) and...
Honolulu—A 2-year trial of patients with Parkinson’s disease (PD) and motor fluctuations found the addition of daily safinamide increased the amount of time each day in which patients experienced symptom relief with levodopa (ON time) and...
Honolulu—A 2-year trial of...
07/19/2011
First Report Managed Care
Feature
07/19/2011

Christin Melton

Christin Melton
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data from two phase 3 studies, presented at a poster session during the AAN meeting, found oral fingolimod more effective at preventing relapse in patients with multiple sclerosis (MS) than interferon beta-1a or...
Honolulu—An analysis of data...
07/19/2011
First Report Managed Care
Feature
07/19/2011

Christin Melton

Christin Melton
Honolulu—The investigational drug teriflunomide demonstrated consistent reductions in rates of relapse and disease progression among patients with relapsing-remitting multiple sclerosis (MS), independent of patient demographics and disease...
Honolulu—The investigational drug teriflunomide demonstrated consistent reductions in rates of relapse and disease progression among patients with relapsing-remitting multiple sclerosis (MS), independent of patient demographics and disease...
Honolulu—The investigational...
07/19/2011
First Report Managed Care
Feature
07/19/2011

Christin Melton

Christin Melton
Honolulu—Data from the phase 3 FLAME (Fluoxetine in Motor Recovery of Patients with Acute Ischaemic Stroke) trial demonstrate that starting patients on a 20-mg dose of daily fluoxetine promptly after an ischemic stroke contributes to better...
Honolulu—Data from the phase 3 FLAME (Fluoxetine in Motor Recovery of Patients with Acute Ischaemic Stroke) trial demonstrate that starting patients on a 20-mg dose of daily fluoxetine promptly after an ischemic stroke contributes to better...
Honolulu—Data from the phase 3...
07/19/2011
First Report Managed Care

Department

Conference Insider
07/19/2011

Tim Casey

Tim Casey
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online...
07/19/2011
First Report Managed Care
Conference Insider
07/19/2011

Tim Casey

Tim Casey
San Francisco—In a study of people with allergist-confirmed peanut allergy, researchers found that healthcare facilities underprescribed epinephrine autoinjectors, and patients did not use epinephrine as often as guidelines recommended. The...
San Francisco—In a study of people with allergist-confirmed peanut allergy, researchers found that healthcare facilities underprescribed epinephrine autoinjectors, and patients did not use epinephrine as often as guidelines recommended. The...
San Francisco—In a study of...
07/19/2011
First Report Managed Care

News

Conference Insider
07/19/2011

Tim Casey

Tim Casey
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online questionnaires completed by parents of children with food allergies found that medical professionals only recognized and treated approximately one third of initial reactions to food allergies that led to anaphylaxis.
An analysis of online...
07/19/2011
First Report Managed Care

Advertisement

Advertisement

Advertisement